Who owns ACHIEVE LIFE SCIENCES INC?
- Ticker: ACHV
- CUSIP Number: 004468500
Tip: Access positions for across all investors
Analyze quarterly positions in Achieve Life Sciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Achieve Life Sciences stock
Who bought or sold ACHIEVE LIFE SCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Franklin Resources | 4.4M | $22M | 18747% | Dec 2025 |
|
| Propel Bio Management | 3.8M | $19M | 0% | Dec 2025 |
|
| Vanguard Group | 2.5M | $12M | 1% | Dec 2025 |
|
| Simplify Asset Management | 1.2M | $5.9M | 0% | Dec 2025 |
|
| Marshall Wace | 1.0M | $5.1M | 32% | Dec 2025 |
|
| Nantahala Capital Management | 649k | $3.2M | 0% | Dec 2025 |
|
| LPL Financial | 633k | $3.1M | 91% | Dec 2025 |
|
| Raymond James Financial | 600k | $3.0M | 31% | Dec 2025 |
|
| Geode Capital Management | 600k | $3.0M | 18% | Dec 2025 |
|
| Susquehanna International | 554k | $2.8M | 21% | Dec 2025 |
|
| KVP Capital Advisors | 462k | $2.3M | 100% | Dec 2025 |
|
| Goldman Sachs Group | 451k | $2.2M | 101% | Dec 2025 |
|
| Two Sigma Investments | 439k | $1.4M | 100% | Sep 2025 |
|
| BlackRock | 419k | $2.1M | 7% | Dec 2025 |
|
| Pathstone Holdings | 417k | $1.9M | -17% | Dec 2025 |
|
| Jane Street | 396k | $2.0M | 428% | Dec 2025 |
|
| UBS Group | 285k | $1.4M | 260% | Dec 2025 |
|
| Millennium Management | 238k | $748k | -39% | Sep 2025 |
|
| None | 235k | $1.2M | 100% | Dec 2025 |
|
| State Street Corporation | 234k | $1.2M | 6% | Dec 2025 |
|
| Northern Trust | 230k | $1.1M | 5% | Dec 2025 |
|
| 683 Capital Management | 215k | $1.1M | 100% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 168k | $835k | 54076% | Dec 2025 |
|
| Squarepoint Ops | 165k | $818k | -56% | Dec 2025 |
|
| Royal Bank of Canada | 155k | $487k | 31% | Sep 2025 |
|
| Renaissance Technologies | 153k | $758k | -51% | Dec 2025 |
|
| Two Sigma Advisers | 110k | $347k | 100% | Sep 2025 |
|
| Barclays | 110k | $547k | 11003100% | Dec 2025 |
|
| Ronald Blue Trust | 86k | $427k | -13% | Dec 2025 |
|
| Alpine Partners VI | 84k | $415k | 100% | Dec 2025 |
|
| Point72 Asset Management | 75k | $374k | 100% | Dec 2025 |
|
| Wells Fargo & Company | 70k | $348k | -2% | Dec 2025 |
|
| Caption Management | 68k | $336k | -66% | Dec 2025 |
|
| Hudson Bay Capital Management | 68k | $336k | 100% | Dec 2025 |
|
| Manchester Financial | 59k | $294k | 27% | Dec 2025 |
|
| Citadel Advisors | 55k | $174k | 6% | Sep 2025 |
|
| Advisor Group Holdings | 54k | $268k | 90% | Dec 2025 |
|
| Dimensional Fund Advisors | 52k | $261k | 0% | Dec 2025 |
|
| ADAR1 Capital Management | 48k | $238k | 0% | Dec 2025 |
|
| Graham Capital Management | 43k | $212k | 100% | Dec 2025 |
|
| Cubist Systematic Strategies | 36k | $112k | 100% | Sep 2025 |
|
| Members Wealth | 30k | $153k | 100% | Dec 2025 |
|
| Rockefeller Capital Management | 30k | $149k | 0% | Dec 2025 |
|
| Goldstone Financial Group | 24k | $120k | 100% | Dec 2025 |
|
| Lighthouse Investment Partners | 24k | $118k | 100% | Dec 2025 |
|
| Jump Financial | 21k | $104k | 100% | Dec 2025 |
|
| Robertson Stephens Wealth Management | 20k | $99k | 100% | Dec 2025 |
|
| Charles Schwab Investment Management | 20k | $99k | 100% | Dec 2025 |
|
| XTX Topco | 19k | $95k | -78% | Dec 2025 |
|
| Hrt Financial | 19k | $93k | 100% | Dec 2025 |
|
| Berkshire Asset Management | 18k | $56k | 0% | Sep 2025 |
|
| Simplex Trading | 17k | $86k | 100% | Dec 2025 |
|
| Leucadia National Corporation | 17k | $84k | 100% | Dec 2025 |
|
| Next Capital Management | 16k | $80k | 0% | Dec 2025 |
|
| SBI Securities | 14k | $70k | 0% | Dec 2025 |
|
| Qube Research & Technologies | 13k | $67k | -73% | Dec 2025 |
|
| Magnolia Capital Advisors | 13k | $64k | 100% | Dec 2025 |
|
| Windsor Capital Management | 11k | $54k | 0% | Dec 2025 |
|
| Madison Park Capital Advisors | 10k | $50k | 0% | Dec 2025 |
|
| Point72 Asia | 7.5k | $24k | 100% | Sep 2025 |
|
| FMR | 7.0k | $22k | -24% | Sep 2025 |
|
| Steward Partners Investment Advisory | 4.6k | $23k | 100% | Dec 2025 |
|
| Hanson McClain Advisors | 3.0k | $15k | 0% | Dec 2025 |
|
| Tower Research Capital | 2.8k | $14k | 100% | Dec 2025 |
|
| Brian McDonald | 2.4k | $12k | -1% | Dec 2025 |
|
| Federation des caisses Desjardins du Quebec | 2.0k | $9.9k | 0% | Dec 2025 |
|
| CWM | 1.7k | $8.0k | 0% | Dec 2025 |
|
| Capital Analysts | 700.00 | $3.0k | 37% | Dec 2025 |
|
| Sittner & Nelson | 673.00 | $2.9k | 0% | Dec 2025 |
|
| Optiver Holding B.V. | 490.00 | $2.4k | 0% | Dec 2025 |
|
| Jones Financial Companies, L.L | 200.00 | $994.000000 | 100% | Dec 2025 |
|
| Point72 | 189.00 | $594.990900 | 100% | Sep 2025 |
|
| Russell Investments | 150.00 | $745.995000 | 0% | Dec 2025 |
|
| Cornerstone Planning Group | 100.00 | $436.000000 | 669% | Dec 2025 |
|
| Jpmorgan Chase & Co | 19.00 | $60.000100 | 100% | Sep 2025 |
|
| SRS Capital Advisors | 10.00 | $50.000000 | 0% | Dec 2025 |
|
| Parkside Financial Bank & Trust | 5.00 | $25.000000 | 100% | Dec 2025 |
|
Who sold out of Achieve Life Sciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Clearline Capital | Sep 2025 | 451k | $1.4M |
| Shay Capital | Sep 2025 | 290k | $912k |
| Alyeska Investment Group | Sep 2025 | 178k | $562k |
| Brevan Howard Capital Management | Jun 2025 | 64k | $145k |
| AQR Capital Management | Jun 2025 | 25k | $57k |
| Sender Co & Partners | Sep 2025 | 25k | $79k |
| OMERS Administration Corporation | Sep 2025 | 25k | $78k |
| Resources Investment Advisors | Sep 2025 | 20k | $63k |
| Group One Trading | Sep 2025 | 8.8k | $28k |
| FNY Investment Advisers | Sep 2025 | 5.0k | $15k |
| Stephens Consulting | Sep 2025 | 3.0k | $9.5k |
| Pnc Financial Services | Sep 2025 | 826.00 | $2.6k |